Lipocine inc. (LPCN)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11
Assets
Current assets:
Cash and cash equivalents

15,134

9,728

6,664

3,664

8,222

8,077

4,802

1,602

8,561

3,210

9,270

16,631

6,936

5,560

4,706

12,373

14,114

20,007

23,925

38,297

24,764

27,666

31,667

34,164

41,772

45,263

36,839

0

0

5,377

0

3

17

22

Restricted cash

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable investment securities

448

4,340

4,880

-

-

7,173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable investment securities

-

-

-

10,812

9,300

-

12,077

18,488

19,201

18,257

16,408

11,194

19,860

21,279

24,132

20,565

24,098

24,375

17,868

5,571

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest income

9

16

10

15

16

38

29

46

47

23

9

13

35

38

115

104

159

144

146

99

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Litigation insurance recovery

-

-

-

-

-

-

0

0

3,566

3,319

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

373

545

754

148

411

520

728

113

247

408

453

88

262

329

457

154

268

350

347

181

186

229

285

1,273

256

770

251

-

-

90

-

-

-

-

Related-party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

3

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

9

9

Total current assets

20,965

19,630

17,310

19,641

22,950

20,809

22,638

25,250

31,624

25,219

26,142

27,927

27,095

27,208

29,411

33,197

38,641

44,877

42,289

44,149

24,950

27,895

31,953

35,437

42,029

46,033

37,090

0

0

5,471

0

3

27

32

Property and equipment, net of accumulated depreciation of $1,140,942 and $1,140,143, respectively

2

3

7

11

15

18

23

27

32

75

82

89

96

103

111

119

108

75

82

79

82

73

40

24

27

28

34

-

-

49

-

-

-

-

Long-term marketable investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

400

6,032

9,543

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

23

23

23

23

23

23

23

23

23

30

30

30

30

30

30

30

23

23

23

23

23

23

23

23

45

45

45

-

-

45

-

-

-

-

Total assets

20,991

19,658

17,341

19,676

22,989

20,851

22,685

25,302

31,680

25,325

26,255

28,047

27,222

27,342

29,554

33,347

38,773

45,377

48,428

53,796

25,057

27,993

32,017

35,485

42,102

46,107

37,170

0

0

5,566

0

3

27

32

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,654

1,182

1,360

116

517

671

239

406

388

598

803

1,113

853

245

864

989

1,077

507

456

398

379

306

399

641

772

1,027

1,483

-

-

87

-

-

-

-

Litigation settlement payable

-

-

-

-

-

-

0

0

4,250

4,250

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

738

449

540

993

426

487

488

886

305

1,497

1,680

1,786

1,491

1,080

707

1,595

1,916

2,884

1,722

1,266

957

1,327

1,657

1,028

727

256

144

-

-

107

-

-

-

-

Debt - current portion

1,666

3,333

3,333

3,333

3,333

3,333

2,341

1,549

1,340

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

17

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

14

-

6

-

-

7

Due to shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

0

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

7

-

Due to shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Total current liabilities

4,059

4,964

5,234

4,442

4,277

4,491

3,069

2,843

6,283

6,345

2,484

2,899

2,344

1,326

1,572

2,584

2,994

3,391

2,178

1,665

1,337

1,633

2,056

1,670

1,500

1,283

1,628

17

14

212

6

4

7

7

Debt - non-current portion

4,688

3,814

4,601

5,383

6,160

6,926

7,853

8,580

8,724

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

5,691

4,591

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable, noncurrent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

37

-

-

-

-

Total liabilities

14,439

13,370

9,836

9,826

10,437

11,418

10,923

11,423

15,008

6,345

2,484

2,899

2,344

1,326

1,572

2,584

2,994

3,391

2,178

1,665

1,337

1,633

2,056

1,670

1,500

1,283

1,628

-

-

250

-

-

-

-

Commitments and contingencies (notes 5, 7, 8 and 10)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

Stockholders' equity:
Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized; zero issued and outstanding

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

-

-

-

-

Common stock, par value $0.0001 per share, 100,000,000 shares authorized; 47,860,209 and 37,655,175 issued and 47,854,499 and 37,649,465 outstanding

4

3

2

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

0

0

0

Additional paid-in capital

163,426

157,391

155,318

154,600

153,872

147,533

146,638

146,304

145,850

145,423

144,878

141,554

135,199

131,481

130,471

130,011

129,270

128,502

128,094

127,619

94,952

94,636

94,197

93,957

93,732

92,686

79,015

70

70

42,590

70

70

29

29

Treasury stock at cost, 5,710 shares

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

40

-

0

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-

-0

0

2

1

-0

-3

-11

-19

-4

-0

-0

-5

-8

0

5

2

-32

5

-10

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-156,837

-151,067

-147,775

-144,714

-141,284

-138,059

-134,834

-132,375

-129,119

-126,399

-121,068

-116,367

-110,278

-105,416

-102,450

-99,215

-93,454

-86,445

-81,811

-75,439

-71,192

-68,237

-64,197

-60,103

-53,131

-47,864

-43,474

-

-

-37,274

-

-

-

-

(Deficit) accumulated during development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

88

85

-

76

-71

-9

-5

Total stockholders' equity

6,552

6,287

7,505

9,850

12,551

9,433

11,761

13,878

16,672

18,979

23,771

25,147

24,877

26,016

27,981

30,763

35,779

41,985

46,249

52,131

23,720

26,359

29,960

33,815

40,601

44,823

35,542

-17

-14

5,316

-6

-0

20

24

Total liabilities and stockholders' equity

20,991

19,658

17,341

19,676

22,989

20,851

22,685

25,302

31,680

25,325

26,255

28,047

27,222

27,342

29,554

33,347

38,773

45,377

48,428

53,796

25,057

27,993

32,017

35,485

42,102

46,107

37,170

0

0

5,566

0

3

27

32